Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120

Brain Research
O BarakR Yirmiya

Abstract

Intracerebroventricular (i.c.v.) administration of HIV-1 glycoprotein 120 (gp120), the envelope protein used by the virus to gain access into immune cells, induces neurobehavioral alterations in rats. To examine the role of proinflammatory cytokines in mediating these effects, we measured the effects of gp120 on brain proinflammatory cytokine expression and the effects of anti-inflammatory agents, including interleukin-1 receptor antagonist (IL-1ra), pentoxifylline (a TNFalpha synthesis blocker) and IL-10, on gp120-induced sickness behavior. I.c.v. administration of gp120 induced the expression of IL-1beta, but not TNFalpha, mRNA in the hypothalamus, 3 h after the injection. Pretreatment of rats with IL-1ra, but not with pentoxifylline, significantly attenuated gp120-induced anorexia and loss in body weight, whereas both agents had no effect on gp120-induced reduction in locomotor activity in the open field. Pretreatment with either IL-1ra and pentoxifylline simultaneously, or with IL-10, produced effects that were similar to the effects of IL-1ra alone. Together, these findings indicate that IL-1, but not TNFalpha, mediates some of the behavioral effects of acute gp120 administration, suggesting that brain IL-1 may be involved...Continue Reading

Citations

May 7, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·James KebleshHuangui Xiong
Jun 27, 2006·European Journal of Clinical Investigation·N A C H Brabers, H S L M Nottet
Nov 22, 2014·Current Psychiatry Reports·Maria Giulia NanniLuigi Grassi
Jul 17, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Jonathan PalmaKhalid Benamar
Jul 20, 2019·Cellular & Molecular Immunology·Xiaolong HeHong Cao
Aug 5, 2006·The Journal of Biological Chemistry·Barbara VivianiMarina Marinovich
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Michael VigoritoSulie L Chang
Nov 16, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sulie L Chang, Kaitlyn P Connaghan
Jan 28, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Hui Qin XingShuji Izumo
Sep 19, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·S Alex MarshallTodd E Thiele
Aug 29, 2012·Expert Opinion on Therapeutic Targets·Michael MaesRaz Yirmiya
Jul 12, 2020·Fluids and Barriers of the CNS·Amila OmeragicReina Bendayan
Oct 19, 2004·Molecular Immunology·Cornelia SpethSieghart Sopper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.